Summary Summary Short summary of a recent publication, written by scientific experts.

Development of new brain MRI lesions in children with MOG-antibody associated disease

Takeaway

  • New silent brain lesions developed in some patients with anti-MOG antibody-related disease (MOGAD) and did not predict clinical relapse; they were less frequent in children with MOGAD than in children with multiple sclerosis (MS) and were rare in children with antibody-negative non-MS demyelination.

Why this matters

    Approximately 25% of children with monophasic or relapsing MOGAD experience clinical relapse, but it is unknown whether they develop new silent magnetic resonance imaging (MRI) lesions and whether these lesions predict clinical relapse. Understanding these relationships will optimize MRI frequency and decision-making concerning chronic immune therapies in children.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.

Learn more

Imaging Paediatric Neurology Multiple Sclerosis MOGAD Relapse Pediatric MRI lesions CNS demyelination